Dr Reddys Laboratories (RDY) Other Non-Current Assets (2009 - 2026)
Dr Reddys Laboratories' Other Non-Current Assets came in at $11.74 million for the quarter ended Jun 30, 2026, up 7.0% from $10.97 million a year earlier but down 12.5% from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Other Non-Current Assets (2009 - 2026) Analysis & Trends
As of Mar 31, 2026, Dr Reddys Laboratories' Other Non-Current Assets was $13 million, up 8.3% from the prior year.
- Other Non-Current Assets carries a five-year compound annual growth rate of 3.4% (years ended Mar 2021 to Mar 2026).
- Going back by year, Other Non-Current Assets was $12 million in the year ended Mar 31, 2025 (-40.0%), $20 million in the year ended Mar 31, 2024 (+100.0%), $10 million in the year ended Mar 31, 2023 (-16.7%) and $12 million in the year ended Mar 31, 2022 (+9.1%).
- The five-year range for quarterly Other Non-Current Assets is $9.73 million (the quarter ended Mar 31, 2023) to $23.56 million (the quarter ended Jun 30, 2022).
- Year-over-year, Other Non-Current Assets increased in four of the last eight quarters, with an average decline of 1.8%.
- The fastest year-over-year change in Other Non-Current Assets over five years came in the quarter ended Jun 30, 2022 (growth of 106.4%), and the weakest in the quarter ended Jun 30, 2023 (a decline of 57.6%).
- Business Quant data shows RDY's Other Non-Current Assets at $13.41 million (quarter ended Mar 31, 2026), $12.31 million (quarter ended Dec 31, 2025) and $12.29 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Dr Reddys Laboratories | 10.53 Bn | 9.72 Bn | 396.53 Mn | 11.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.74 Mn |
| Mar 31, 2026 | 13.41 Mn |
| Dec 31, 2025 | 12.31 Mn |
| Sep 30, 2025 | 12.29 Mn |
| Jun 30, 2025 | 10.97 Mn |
| Mar 31, 2025 | 11.22 Mn |
| Dec 31, 2024 | 16.11 Mn |
| Sep 30, 2024 | 18.03 Mn |
| Jun 30, 2024 | 19.89 Mn |
| Mar 31, 2024 | 19.65 Mn |
| Dec 31, 2023 | 13.55 Mn |
| Sep 30, 2023 | 9.82 Mn |
| Jun 30, 2023 | 9.99 Mn |
| Mar 31, 2023 | 9.73 Mn |
| Dec 31, 2022 | 22.30 Mn |
| Sep 30, 2022 | 22.59 Mn |
| Jun 30, 2022 | 23.56 Mn |
| Mar 31, 2022 | 11.89 Mn |
| Dec 31, 2021 | 12.52 Mn |
| Sep 30, 2021 | 11.16 Mn |
API Access
Dr Reddys Laboratories Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();